Latest News and Press Releases
Want to stay updated on the latest news?
-
Westford USA, June 14, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Biologics Market will attain a value of USD 1125.55 Billion by 2031, with a CAGR of 10.40% over the forecast period...
-
Jersey City, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Biologics Market is estimated to reach over USD 718.97 billion by 2031, exhibiting a CAGR of 7.50% during the forecast period. A...
-
Pune, March 06, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global biologics market accounted for USD 382 billion in 2022. and is projected to reach USD 893 billion by 2032, exhibiting a...
-
SYDNEY, Jan. 16, 2023 (GLOBE NEWSWIRE) -- "Biologics Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key segments, Porter's Five...
-
Brooklyn, New York, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Reports and Insights (R&I) has published a new report titled, “Biologics Market: Opportunity Analysis and Future Assessment 2022-2030”...
-
New York, United States, June 23, 2022 (GLOBE NEWSWIRE) -- The market for biologics is growing steadily because companies are spending a lot of money to improve the places where they make their...
-
Ottawa, April 20, 2022 (GLOBE NEWSWIRE) -- The global biologics market size was valued at US$ 366.43 billion in 2021. A biologic medication is a product that is made from live organisms and contains...
-
Pune, May 11, 2020 (GLOBE NEWSWIRE) -- The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The...
-
New York, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product...
-
Pune, India, April 04, 2019 (GLOBE NEWSWIRE) -- Global Biologics Market Size is expected to reach a valuation of USD 285,520.4 million by the end of the forecast period from 2018 to 2023, according...